Sector: Pharmaceuticals & Biotechnology

Small Cap

Balaxi Pharma Share Price

Balaxi Pharmaceuticals Ltd.

₹19.75

-0.18(-0.90%)

Trade Now

27th Feb 2026 | 3:27 PM

NSE : BALAXI

Open Free Demat Account

Balaxi Pharma Performance

Price Movement

₹19.75

₹19.60

₹20.33

↘ Today's Low↗ Today's High

1 Year Performance

₹19.75

₹19.60

₹76.10

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹20.33

Low₹19.60

Open at₹19.93

Prev Close₹19.93

Volumes58.87 K

Avg Price₹19.76

Lower Circuit₹15.95

Upper Circuit₹23.91

Historical Performance

3M High₹38.84

3M Low₹19.60

1 Yr High₹76.10

1 Yr Low₹19.60

3 Yr High₹151.45

3 Yr Low₹19.60

5 Yr High₹151.45

5 Yr Low₹19.60

Balaxi Pharma Fundamentals

Market Cap

Below industry Median

108.90 Cr.

PE Ratio (TTM)

Below industry Median

11.50

Dividend Yield

Net Profit TTM

66% decr over last year

9.44

Net Profit Growth

66% decr over last year

9.44

PEG Ratio

Negative PEG TTM

-0.20

ROE

1016.1% incr over last year

10.81

Operating Revenue TTM

275.73

Operating Revenue Growth

0% decr over last year

Book Value

Low in industry

0.50

MFI

MFI is mid-range

47.84

RSI

RSI is mid-range

30.16

EPS (TTM)

4.54

Debt to Equity

0.22

Face Value

Operating Profit Margin Qtr.

12.88

Operating Profit Qtr.

3.09

Net Profit Qtr.

0.30

Operating Revenue Qtr.

72.54

PB Ratio

0.50

Balaxi Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	24.59	19.31	16.71	9.65	11.16
Operating Expense	23.21	18.54	16.17	10.30	11.06
Operating Profit	1.38	0.78	0.54	-0.65	0.10
Depreciation	0.15	0.12	0.11	0.11	0.11
Interest	0.73	0.62	0.63	0.69	0.57
Tax	0.59	0.98	0.06	0.04	0.59
Net Profit	1.53	3.26	0.19	-1.18	1.74

Balaxi Pharma Technicals

Balaxi Pharmaceuticals Ltd. EMA & SMA

₹19.75

-0.18 (-0.90%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹20.3

Day EMA10 ₹20.7

Day EMA12 ₹20.9

Day EMA20 ₹21.8

Day EMA26 ₹22.4

Day EMA50 ₹25.1

Day EMA100 ₹30.6

Day EMA200 ₹40.4

Balaxi Pharma Support and Resistance

Resistance

First Resistance₹20.58

Second Resistance₹21.23

Third Resistance₹21.67

Support

First Support₹19.49

Second Support₹19.05

Third Support₹18.40

Technical Indicators

Day RSI30.16

Day MFI47.84

Day ADX26.46

Day Commodity Channel Index-91.40

William-91.75

Day MACD-1.48

Day MACD Signal Line-1.50

Day ATR1.26

Day ROC125-56.30

Day ROC21-18.32

Balaxi Pharma Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	66	66	66	66	66	66
FII	16.5	16.5	16	8.9	3.5	1.7
DII	0	0	0	0	0	0.1
Public	17.5	17.5	18	25.1	30.5	32.2

Balaxi Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	86.15 K	1 L	85.87%
Week	89.31 K	1.11 L	80.19%
1 Month	1.05 L	1.54 L	68.08%
6 Month	77.78 K	1.28 L	60.86%

Balaxi Pharma SWOT Analysis

Strengths7

Weakness18

Opportunity0

Threats0

Growth Stars: Strongest Annual EPS Performers

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Companies with Zero Promoter Pledge

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Balaxi Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Balaxi Pharma Stock Comparison

Financials	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Medistep Healthcare Ltd.	Influx Healthtech Ltd.
Price (₹)	₹7.53	₹98	₹100.83	₹107.50	₹22.50	₹207.25
% Change	0.13%	-1.01%	-3.82%	-0.64%	0.00%	-0.36%
Revenue TTM (₹ Cr)	₹104.12	-	₹282.74	-	-	-
Net Profit TTM (₹ Cr)	₹-24.37	-	₹15.30	-	-	-
PE TTM	-2.60	13.00	26.10	-	7.70	35.90
1 Year Return	657	-23.44	-18.29	19.25	-47.67	115.89
ROCE	-5.63	-	-	-	-	-

Similar Stocks

MEDIORG

Medicamen Organics Ltd.

₹ 24.00

+1.05%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 601.00

-0.07%

SENORES

Senores Pharmaceuticals Ltd.

₹ 763.00

-1.49%

INNOVACAP

Innova Captab Ltd.

₹ 665.50

-1.16%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 57.11

-3.37%

SIGACHI

Sigachi Industries Ltd.

₹ 20.20

+0.15%

WINDLAS

Windlas Biotech Ltd.

₹ 754.10

-1.46%

VINEETLAB

Vineet Laboratories Ltd.

₹ 29.99

-1.93%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 459.50

-0.77%

ZIMLAB

Zim Laboratories Ltd.

₹ 69.02

-2.02%

MEDICO

Medico Remedies Ltd.

₹ 44.60

-0.91%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 177.15

-4.19%

LASA

Lasa Supergenerics Ltd.

₹ 7.98

+1.66%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 306.00

+1.86%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 330.50

-0.39%

ORTINGLOBE

Ortin Global Ltd.

₹ 17.19

+4.95%

BROOKS

Brooks Laboratories Ltd.

₹ 66.60

-2.06%

RPGLIFE

RPG Life Sciences Ltd.

₹ 1867.80

-2.17%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 104.03

-1.21%

ALPA

Alpa Laboratories Ltd.

₹ 65.54

-0.05%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 127.53

-0.70%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 382.80

-1.69%

NECLIFE

Nectar Lifesciences Ltd.

₹ 12.19

+0.08%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 28.85

-3.74%

FAQ's on BALAXI

What is the Market Capitalization of Balaxi Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Balaxi Pharmaceuticals Ltd. is approximately ₹ 108.9 Cr.

What are the PE and PB ratios for Balaxi Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Balaxi Pharmaceuticals Ltd. is 11.5, and the Price-to-Book (PB) ratio is 0.5.

What is the 52-Week High and Low for Balaxi Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Balaxi Pharmaceuticals Ltd. shares was ₹ 76.1, and the lowest price was ₹ 19.6.

Who are the major shareholders of Balaxi Pharmaceuticals Ltd.?

Significant shareholdings in Balaxi Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Balaxi Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Balaxi Pharmaceuticals Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy